Johan Kahlstrom
Johan Kahlstrom is the managing director of Novartis UK and Ireland, who recently highlighted the challenges facing NHS patients in accessing new treatments due to rising drug costs and outdated assessment methods.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 2 | 4.50 | 0.08% | +0% | 67,886,011 | 56,713 | $2,700,000 | 2,256$ |
| Totals | 2 | 67,886,011 | 56,713 | $2,700,000 | 2,256$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Johan Kahlstrom from Novartis expressed concerns about the declining competitiveness of the UK market.
4
United Kingdom:
Johan Kahlstrom is the UK boss of Novartis who expressed concerns about the UK's investment climate for pharmaceuticals.
5